Related Experiment Videos
Ras pathway signals are required for notch-mediated oncogenesis
K Fitzgerald1, A Harrington, P Leder
1Department of Genetics, Harvard Medical School, Howard Hughes Medical Institute, 200 Longwood Avenue, Boston, Massachusetts, MA 02115, USA.
Oncogene
|September 12, 2000
Summary
Activated Notch signaling contributes to cancer by requiring Erk/MAP kinase and PI-3 kinase pathways. These pathways are essential for malignant transformation, not Src-like kinases or PKA/PKC signals.
Area of Science:
- Cell biology
- Developmental biology
- Cancer research
Background:
- Notch receptors and ligands (Delta, Jagged) regulate cell fate during development.
- Mutant Notch receptors are implicated in human T-cell leukemia and mouse mammary carcinomas.
- Activated Notch signaling can induce tumors, suggesting collaboration with other genetic events.
Purpose of the Study:
- To investigate which signal transduction pathways cooperate with activated Notch4 in malignant transformation.
- To identify key signaling pathways involved in Notch-induced tumorigenesis.
Main Methods:
- Assessment of four distinct signal transduction pathways.
- Analysis of the role of Src-like kinases (Lck, Fyn), protein kinase A (PKA), and protein kinase C (PKC).
- Evaluation of the involvement of Erk/MAP kinase and PI-3 kinase pathways downstream of Ras.
Main Results:
- Malignant transformation by Notch did not depend on Lck, Fyn, PKA, or PKC signaling.
- Active signals from Erk/MAP kinase and PI-3 kinase pathways downstream of Ras are required for Notch-induced transformation.
- These findings highlight specific pathways crucial for Notch-mediated oncogenesis.
Conclusions:
- Erk/MAP kinase and PI-3 kinase pathways are essential collaborators in Notch-driven malignant transformation.
- The study elucidates key downstream effectors of Ras signaling in Notch-induced cancer.
- Understanding these pathways offers potential targets for cancer therapy.